ReportsnReports – The Global Catheters Market
Upcoming SlideShare
Loading in...5
×
 

ReportsnReports – The Global Catheters Market

on

  • 549 views

BCC Research’s goal in conducting this study was to determine the present status of the worldwide catheter market and to evaluate its potential over the 5-year period from 2007 to 2012. An ...

BCC Research’s goal in conducting this study was to determine the present status of the worldwide catheter market and to evaluate its potential over the 5-year period from 2007 to 2012. An assessment of the worldwide catheter market was performed while considering all of its important segments such as cardiovascular, urology, neurovascular, intravenous, and specialty catheters.

Statistics

Views

Total Views
549
Views on SlideShare
548
Embed Views
1

Actions

Likes
1
Downloads
0
Comments
0

1 Embed 1

http://www.google.com 1

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

ReportsnReports – The Global Catheters Market ReportsnReports – The Global Catheters Market Document Transcript

  • The Global Catheters MarketReportsnReports.com adds BCC Research Market Research Report “The Global CathetersMarket’’ to its store.BCC Research’s goal in conducting this study was to determine the present status ofthe worldwide catheter market and to evaluate its potential over the 5-year period from2007 to 2012. An assessment of the worldwide catheter market was performed whileconsidering all of its important segments such as cardiovascular, urology, neurovascular,intravenous, and specialty catheters.SCOPE OF STUDYThis report contains: Descriptions of catheter technologies and their potential applications The current global market status of catheters, trends, and forecasts for growth over the next 5 years Technological issues, including the latest developments A discussion of regulatory issues affecting the current market and their potential impact on future markets Profiles of major manufacturers/suppliers of catheter technologies.METHODOLOGYBCC Research presents an analysis of each segment of catheters depending on itsapplication, using a base year of 2007. Estimated values used are based on whatmanufacturers have paid in non-depreciated dollars.INFORMATION SOURCESBoth primary and secondary sources were used in this research. Major sources of primaryresearch information were numerous key players in this industry. Secondary researchsources include various Internet sources, company Web sites, financial and tradeinformation, and government sources.ABOUT THE AUTHORAlpita Shah has an MBA in Healthcare and a B.S. in life sciences. She has published manyarticles and reports in the areas of biotechnology and healthcare. She is familiar with theoperations of many healthcare companies.Table of ContentsChapter- 1: INTRODUCTION — Complimentary 3STUDY GOALS AND OBJECTIVES 1REASONS FOR DOING THE STUDY 1
  • SCOPE OF REPORT 1METHODOLOGY 1INTENDED AUDIENCE 2INFORMATION SOURCES 2ANALYST CREDENTIALS 2RELATED REPORTS 2BCC ONLINE SERVICES 2DISCLAIMER 3Chapter-2: SUMMARY 3SUMMARY 4SUMMARY TABLE GLOBAL CATHETER MARKET, THROUGH 2014 ($ MILLIONS) 5SUMMARY FIGURE GLOBAL CATHETER MARKET, 2008 AND 2014 (%) 6Chapter-3: OVERVIEW OF GLOBAL CATHETER INDUSTRY 19ORIGINS 7CATHETER CONSTRUCTION 8CATHETER APPLICATIONS 8TYPES OF CATHETERS 9CARDIOVASCULAR CATHETERS 9Diagnostic Procedures and Cardiac Catheterization 10TABLE 1 INDICATIONS FOR CARDIAC CATHETERIZATION 10TABLE 1 (CONTINUED) 11TABLE 2 TYPES OF CARDIAC CATHETERS 11Angiography Catheters 11Electrophysiology (EP) Catheters 12Percutaneous Coronary Intervention (PCI) Catheters 13TABLE 3 PTCA PROCEDURES 13Rapid Exchange PTCA Balloon Catheters 14Over – the-Wire PTCA Catheters 14Guiding Catheter 14UROLOGICAL CATHETERS 15Types of Urinary Catheterizations 16Intermittent Catheterization 16Indwelling Catheterization 16Suprapubic Catheterization 17Male External Condom Catheters 18NEUROVASCULAR CATHETERS 18INTRAVENOUS (IV) CATHETERS 19Single-Lumen Catheters 19Multi-Lumen Catheter 20Specialty IV Catheters 20Peripheral Vein Catheter 20Central Venous Catheter 20Peripherally Inserted Central Catheters (PICCs) 21TABLE 4 COMPLICATIONS DUE TO IV CATHETERS 22SPECIALTY CATHETERS 22Thermodilution Catheters 22
  • Suction Catheters 23Oximetry Catheters 23END-USER PREFERENCES 24SIZE OF CATHETER 24MATERIAL USED 24COATING 25DURATION OF CATHETER IN THE BODY 25INFECTION 25COST 25Chapter-4: CATHETERS AND WORLD DEMOGRAPHICS 4TABLE 5 U.S. RATES OF CARDIOVASCULAR PROCEDURES, 2004 AND 2006*(THOUSANDS) 26WORLDWIDE PROCEDURES 27TABLE 6 SELECTED WORLDWIDE CORONARY PROCEDURES, 2008 (PER 100,000POPULATION) 27WORLDWIDE ECONOMIC DEMOGRAPHICS 28TABLE 7 HEALTHCARE EXPENDITURE AS A PERCENTAGE OF GDP BY COUNTRY,1980 – 2005 (%) 28TABLE 7 (CONTINUED) 29WORLDWIDE POPULATION GROWTH 29Chapter-5: CATHETER MATERIALS 7KEY CHARACTERISTICS OF CATHETER MATERIALS 30TABLE 8 CHARACTERISTICS OF CATHETER MATERIALS 30SURFACE CHARACTERISTICS 31RADIOPACITY 31COMPONENT MATERIALS 31LATEX 32SILICONE 32TEFLON (FLUOROPOLYMER) 33POLYURETHANE 33POLYVINYL CHLORIDE (PVC) 33POLYETHYLENE 33CATHETER COATINGS 34SILICONE ELASTOMER 34HYDROPHILIC COATING 34ANTIMICROBIAL COATING 35Silver Coating 35ADVANTAGES AND DISADVANTAGES OF CATHETER MATERIALS 35TABLE 9 ADVANTAGES AND DISADVANTAGES OF CATHETER MATERIALS 36Chapter-6: ANALYSIS OF THE GLOBAL CATHETER MARKET 26FACTORS INFLUENCING MARKET GROWTH 37FIGURE 1 FACTORS INFLUENCING THE MEDICAL DEVICE MARKET 38DEMOGRAPHICS 38
  • SURGICAL AND MEDICAL TRENDS 38Catheter Reuse 39REIMBURSEMENT 39EMERGING TECHNOLOGY 39PRODUCT DISTRIBUTION 40PURCHASING TRENDS 40TREATMENT COSTS 40LEADING MANUFACTURERS 41TABLE 10 REVENUES OF KEY CATHETER MANUFACTURERS, 2007 AND 2008 ($MILLIONS) 41KEY MARKET DRIVERS 41INCREASE IN PROCEDURES HAS LED TO INCREASED DEMAND FOR CATHETERS 42INCREASED DEMAND FOR DISPOSABLE CATHETERS DUE TO RISK OF INFECTION AND AIDS42NEW TECHNOLOGIES IN CATHETERS HAVE INCREASED CATHETER USE 42INCREASE IN MINIMALLY INVASIVE PROCEDURES REQUIRING CATHETERS HAS INCREASEDSALES 42ADVANCES IN IMAGING TECHNOLOGY HAS LED TO NEW APPLICATIONS REQUIRING THEUSE OF CATHETERS 43KEY MARKET RESTRAINTS 43PRICE EROSIONS DUE TO FIERCE COMPETITION ARE SHRINKING REVENUES 43LONG FDA APPROVAL TIMES ARE RESULTING IN DELAYED LAUNCHES OF NEW PRODUCTS43REIMBURSEMENT ISSUES HAVE AFFECTED THE USE OF TECHNOLOGICALLY ADVANCEDCATHETERS 44EXPERIENCED PHYSICIANS OFTEN ARE RELUCTANT TO ACCEPT NEW DEVICETECHNOLOGIES 44GLOBAL CATHETER REVENUE ANALYSIS 44TABLE 11 PROJECTED GLOBAL CATHETER MARKET BY SEGMENT, THROUGH 2014($ MILLIONS 45FIGURE 2 PROJECTED GLOBAL CATHETER MARKET, 2009 ($ MILLIONS) 45FIGURE 2 (CONTINUED) 46TABLE 12 PROJECTED GLOBAL CATHETER MARKET SHARES BY SEGMENT, 2008AND 2014 (%) 47FIGURE 3 GLOBAL CATHETER MARKET SHARES BY SEGMENT, 2009 AND 2014 (%)48MARKET SHARE FORECAST 49CONSEQUENCES OF THE 2008 ECONOMIC SLOWDOWN 49REVENUES, SHARES, AND PROJECTIONS BY REGION 50TABLE 13 PROJECTED GLOBAL CATHETER MARKET BY REGION, THROUGH 2014 ($MILLIONS) 50TABLE 14 PROJECTED GLOBAL CATHETER MARKET SHARES BY REGION, 2008 AND2014 (%) 51U.S. Catheter Market 51European Catheter Market 52Rest of the World Catheter Market 53REPROCESSED CATHETERS 54COMPETITIVE STRUCTURE 55TYPES OF COMPETITION 56
  • TIERS OF COMPETITION 56MERGERS AND ACQUISITIONS 56TABLE 15 SELECTED KEY MERGERS AND ACQUISITIONS WITHIN THE CATHETERMARKET, 2008-2009 ($) 57END-USER GROUPS 57DISTRIBUTION STRUCTURE 58PURCHASE STRUCTURE 59COMPETITIVE FACTORS 59Regulatory Environment 59Pricing 59Catheter Properties 60Branding 60ANALYSIS OF THE GLOBAL CATHETER MARKET BASED ON STRENGTHS, OPPORTUNITIES,WEAKNESSES, AND THREATS 60STRENGTHS 60OPPORTUNITIES 61WEAKNESSES 61THREATS 62Chapter-7: CARDIOVASCULAR CATHETERS 11KEY MARKET CHALLENGES 63CONTROVERSY REGARDING THE USE OF DRUG-ELUTING STENTS AFFECTS CATHETER USE63PHARMACOLOGICAL APPROACHES ARE THREATENING CATHETER DEMAND 64LACK OF CLINICAL DATA IS HINDERING ACCEPTANCE OF NEWER CATHETERS BYPHYSICIANS 64KEY MARKET DRIVERS 64INCREASES IN THE INCIDENCE OF CARDIOVASCULAR DISEASES IS DRIVING THE NUMBEROF PROCEDURES 64POPULARITY OF ANGIOPLASTY AND STENTS OVER BYPASS SURGERY IS LEADING TO ANINCREASE IN THE USE OF CARDIAC CATHETERS 65ANGIOGRAPHY IS DRIVING THE INCREASE IN THE NUMBER OF DIAGNOSTIC PROCEDURES65INTERVENTIONAL CARDIAC PROCEDURES ARE MORE EFFECTIVE THAN PHARMACEUTICAL-BASED THERAPIES 66KEY MARKET RESTRAINTS 66CONSTANT PRICE EROSION IS LEADING TO DECREASED REVENUES 66DECREASE IN RESTENOSIS IS AFFECTING THE NUMBER OF STENT PROCEDURESPERFORMED 66CATHETER USAGE IS RESTRAINED DUE TO LOW REIMBURSEMENT RATES 67CARDIOVASCULAR CATHETER MARKET ANALYSIS 67TABLE 16 PROJECTED GLOBAL CARDIOVASCULAR CATHETER MARKET BY TYPE,THROUGH 2014 ($ MILLIONS) 67FIGURE 4 PROJECTED GLOBAL CARDIOVASCULAR CATHETER MARKET BY TYPE,2014 ($ BILLIONS) 68ANGIOGRAPHY 69ELECTROPHYSIOLOGY/MAPPING CATHETERS 69BALLOON CATHETERS 69
  • GUIDING CATHETERS 70INTRAVASCULAR ULTRASOUND CATHETERS 70TABLE 17 PROJECTED GLOBAL CARDIOVASCULAR CATHETER MARKET BY TYPE OFPROCEDURE, 2009 AND 2014 (%) 70FIGURE 5 GLOBAL CARDIOVASCULAR CATHETER SHARES BY REGION, 2009 AND2014 (%) 71MARKET SHARES BY COMPANY 72TABLE 18 GLOBAL CARDIOVASCULAR CATHETER MARKET SHARES BY COMPANY,2008 (%) 72FIGURE 6 GLOBAL CARDIOVASCULAR CATHETER MARKET SHARES BY COMPANY,2008 (%) 72CARDIOVASCULAR CATHETER PRODUCTS BY COMPANY 73COMPETITIVE STRUCTURE 73Chapter-8: UROLOGY CATHETER MARKET 8KEY MARKET CHALLENGES 74USE OF LONG-TERM CATHETERS IS THREATENING THE GROWTH OF DISPOSABLECATHETERS 74USE OF CATHETERS HAS DECLINED DUE TO AN INCREASE IN THE NUMBER OF URINARYTRACT INFECTIONS (UTI) 74SOME PHYSICIANS ARE NOT READY TO ACCEPT NEW PRODUCTS DUE TO A LACK OFCLINICAL DATA 75KEY MARKET DRIVERS 75INCREASE IN UROLOGY PROCEDURES IS LEADING TO INCREASED CATHETER USE 75CATHETERS WITH ANTIMICROBIAL COATINGS ARE INCREASING CONFIDENCE IN THE USEOF CATHETERS 75SOME PRODUCTS CAN BE USED BY PATIENTS THEMSELVES, INCREASING PATIENTADOPTION 76KEY MARKET RESTRAINTS 76LENGTHY FDA APPROVAL TIMES HAVE LED TO DELAYS IN THE LAUNCH OF EFFECTIVEANTIMICROBIAL CATHETERS 76OCCURRENCES OF UTI IS DISCOURAGING CATHETER USAGE 76UROLOGY CATHETER MARKET ANALYSIS 76TABLE 19 PROJECTED GLOBAL UROLOGY CATHETER MARKET BY TYPE, THROUGH2014 ($ MILLIONS) 77FIGURE 7 PROJECTED GLOBAL UROLOGY CATHETER MARKET BY TYPE, 2008-2014($ MILLIONS) 78MARKET SHARES AND PROJECTIONS BY TYPE OF CATHETER 78TABLE 20 PROJECTED GLOBAL UROLOGY CATHETER MARKET SHARES BY TYPE,2008 AND 2014 (%) 79FIGURE 8 PROJECTED GLOBAL UROLOGY CATHETER MARKET SHARES BY TYPE,2014 (%) 79Intermittent Catheters 79Foley Catheters 80Other Catheters 80MARKET SHARES BY COMPANY 80TABLE 21 GLOBAL UROLOGY CATHETER MARKET SHARES BY COMPANY, 2008 (%)81
  • UROLOGY CATHETER PRODUCTS BY COMPANY 81COMPETITIVE STRUCTURE 81Chapter-9: NEUROVASCULAR CATHETER MARKET 5KEY MARKET CHALLENGES 82COST OF SPECIALIZED MICROCATHETERS AFFECTS THEIR ADOPTION 82KEY MARKET DRIVERS 82ADVANCES IN IMAGING TECHNOLOGIES ARE CREATING NEW AREAS OF DIAGNOSIS ANDTREATMENT 82STENTING AND ANEURYSM TREATMENTS ARE INCREASING CATHETER USE 82NEW CATHETER TECHNOLOGIES ARE IMPROVING PROCEDURES AND INCREASING DEMAND83MARKET POTENTIAL EXISTS IN UNMET TREATMENT OPTIONS 83KEY MARKET RESTRAINTS 83INCREASED AVAILABILITY OF PHARMACOLOGICAL TREATMENT OPTIONS IS INHIBITINGNEUROCATHETER USE 83SHORTAGE OF PROFESSIONALS QUALIFIED TO PERFORM INVASIVE NEUROLOGICALPROCEDURES IS INFLUENCING NEUROCATHETER SALES 84MANY PATIENTS DIE BEFORE RECEIVING TREATMENT 84NEUROVASCULAR CATHETER MARKET ANALYSIS 84TABLE 22 PROJECTED GLOBAL NEUROVASCULAR CATHETER MARKET, THROUGH2014 ($ MILLIONS) 85MARKET SHARES BY COMPANY 85TABLE 23 GLOBAL NEUROVASCULAR CATHETER MARKET SHARES BY COMPANY,2008 (%) 86NEUROVASCULAR PRODUCTS, BY COMPANY 86COMPETITIVE STRUCTURE 86Chapter-10: INTRAVENOUS CATHETER MARKET 6KEY MARKET CHALLENGES 87LACK OF CLINICAL DATA CHALLENGES ADOPTION OF NEW IV CATHETERS 87MANUFACTURERS FACE PRICE EROSION AND FIERCE COMPETITION 87KEY MARKET DRIVERS 88STRICT CATHETER REPLACEMENT RULES ARE INCREASING SALES 88IV CATHETERS WITH ANTIMICROBIAL COATINGS IMPROVE THEIR MARKETABILITY 88INCREASED APPLICATIONS AND INTRODUCTION OF NEW TECHNOLOGY BOOSTS IVCATHETER SALES 88KEY MARKET RESTRAINTS 89CONSTANT PRICE EROSION IS LEADING REVENUE LOSSES 89REIMBURSEMENT ISSUES REDUCE THE USE OF HIGH-END IV CATHETERS 89INTRAVENOUS CATHETER MARKET ANALYSIS 89TABLE 24 PROJECTED GLOBAL IV CATHETER MARKET BY TYPE, THROUGH 2014 ($MILLIONS) 89FIGURE 9 PROJECTED GLOBAL IV CATHETER MARKET, 2008-2014 ($ MILLIONS) 90MARKET SHARES AND PROJECTIONS BY CATHETER TYPE 90TABLE 25 PROJECTED GLOBAL INTRAVENOUS CATHETER SHARES BY TYPE, 2008AND 2014 (%) 91MARKET SHARES BY COMPANY 91
  • TABLE 26 GLOBAL INTRAVENOUS CATHETER MARKET SHARES BY COMPANY, 2008(%) 92IV CATHETER PRODUCTS BY COMPANY 92COMPETITIVE STRUCTURE 92Chapter-11: SPECIALTY CATHETERS 5KEY MARKET CHALLENGES 93LACK OF CLINICAL DATA TO SUPPORT EFFICACY 93KEY MARKET DRIVERS 93DEMAND FOR ENHANCED MONITORING DEVICES IS LEADING TO MORE SALES 93THE EFFECTIVENESS OF SPECIALTY CATHETERS IS FUELING INTEREST BY MEDICAL STAFFAND PROMOTING THEIR USE 93KEY MARKET RESTRAINTS 94HIGH PRICE OF CATHETERS INHIBITS SALES 94LIMITED INTERNATIONAL EXPANSION DUE TO THE HIGHER COST OF SPECIALTYCATHETERS 94SPECIALTY CATHETER MARKET ANALYSIS 94TABLE 27 PROJECTED GLOBAL SPECIALTY CATHETER MARKET BY TYPE, THROUGH2014 ($ MILLIONS) 94FIGURE 10 PROJECTED GLOBAL SPECIALTY CATHETER MARKET BY TYPE, 2008-2014 ($ MILLIONS) 95MARKET SHARES AND PROJECTIONS BY CATHETER TYPE 95TABLE 28 PROJECTED GLOBAL SPECIALTY CATHETER MARKET SHARES BY TYPE,2008 AND 2014 (%) 96MARKET SHARES BY COMPANY 96TABLE 29 SPECIALTY CATHETER MARKET SHARES BY COMPANY, 2008 (%) 97SPECIALTY PRODUCTS BY COMPANY 97COMPETITIVE STRUCTURE 97Chapter-12: GOVERNMENT REGULATIONS AND ISSUES 18CATHETER MARKET REGULATIONS 98CLASS I MEDICAL DEVICES 98CLASS II 98CLASS III 98TABLE 30 CATHETER TYPES AND CLASS 99TABLE 30 (CONTINUED) 100TABLE 30 (CONTINUED) 101FDA APPROVAL PROCESS 101PREMARKET NOTIFICATION 510(K) 102PREMARKET APPROVAL (PMA) 103INVESTIGATIONAL DEVICE EXEMPTION (IDE) 104ESTABLISHMENT REGISTRATION FORM 105MEDICAL DEVICE LISTING 105QUALITY SYSTEM (QS) REGULATION 106LABELING 107MEDICAL DEVICE REPORTING 107EUROPEAN HEALTHCARE STANDARDS 107REGULATORY DIRECTIVES 108The Active Implantable Medical Device Directive (AIMD) [90/385/EEC] 108
  • The Medical Device Directive (MDD) [93/42/EEC] 108The In Vitro Medical Devices Directive (IVD) [98/79/EC] 108JAPANESE STANDARDS 109CHINESE STANDARDS 109INTERNATIONAL ORGANIZATION FOR STANDARDS (ISO) 110TABLE 31 CATHETER ISO NUMBERS 110DIFFERENCES IN EUROPEAN AND U.S. REGULATIONS 110RECENT FDA 510(K) APPROVALS, EUROPEAN UNION CE APPROVALS, JAPANESEAPPROVALS. 111TABLE 32 SELECTED U.S. FDA 510(K) APPROVALS, CE MARK APPROVAL, ANDJAPANESE APPROVAL OF CATHETERS, 2007 – 2009 111TABLE 32 (CONTINUED) 112TABLE 32 (CONTINUED) 113FDA RECALLS 113MISLABELING 113NONSTERILE CONDITIONS 114MANUFACTURING DEFECTS/MALFUNCTIONS 114TABLE 33 U.S. CATHETER RECALLS IN 2008, 2009 114TABLE 33 (CONTINUED) 115Chapter-13: PATENT ANALYSIS 11GLOBAL PATENT APPLICATIONS, 2008 AND 2009 116TABLE 34 GLOBAL CATHETER PATENT APPLICATIONS, 2008-2009 117CATHETER PATENT ACTIVITY BY ASSIGNEE 117TABLE 35 CATHETER PATENT APPLICATION ACTIVITY BY ASSIGNEE, JANUARY2007-JUNE 2009 (NUMBER OF PATENTS) 117TABLE 35 (CONTINUED) 118GLOBALLY ISSUED PATENTS, BY SEGMENT 118TABLE 36 GLOBAL PATENTS ISSUED, BY SEGMENT, 2008-2009 118TABLE 37 ISSUED CATHETER PATENT SHARES, BY SEGMENT, JANUARY 2007-JUNE2009 (%) 119FIGURE 11 SHARE FOR ISSUED CATHETER PATENTS, BY SEGMENT, JANUARY 2007-JUNE 2009 (%) 119CARDIOVASCULAR CATHETER PATENTS 120TABLE 38 ISSUED CARDIOVASCULAR CATHETER PATENTS BY TYPE, MAY 2007-MAY2009 120FIGURE 12 ISSUED CARDIOVASCULAR CATHETER PATENTS, BY TYPE, MAY 2007-MAY 2009 (%) 120UROLOGY CATHETER PATENTS 121TABLE 39 ISSUED UROLOGY CATHETER PATENTS BY TYPE, JANUARY 2007-JUNE2009 121IV CATHETER PATENTS 121TABLE 40 ISSUED IV CATHETER PATENTS BY TYPE, MAY 2007-MAY 2009 122SPECIALTY CATHETER PATENTS 122NEUROVASCULAR 122MAJOR CATHETER PATENT RECIPIENTS FROM 1999 TO MAY 2009 122TABLE 41 U.S. CATHETER PATENT NUMBERS BY ASSIGNEE, 1999-MAY 2009 122TABLE 41 (CONTINUED) 123TABLE 41 (CONTINUED) 124
  • FIGURE 13 PERCENT OF CATHETER PATENTS ISSUED TO TOP 10 MANUFACTURERS,1999-MAY 2009 (%) 124FIGURE 13 (CONTINUED) 125CATHETER PATENT ACTIVITY BY COUNTRY 125TABLE 42 CATHETER PATENT ACTIVITY BY COUNTRY, JANUARY 2008-JUNE 2009(NUMBER OF PATENTS FILED) 125TABLE 42 (CONTINUED) 126CONCLUSIONS OF THE PATENT ANALYSIS 126Chapter-14: COMPANY PROFILES 39ABBOTT LABORATORIES 127TABLE 43 ABBOTT LABORATORIES’ CATHETER PRODUCTS 127TABLE 43 (CONTINUED) 128ANGIODYNAMICS 128TABLE 44 ANGIODYNAMICS CATHETER PRODUCTS 129ARROW INTERNATIONAL (SEE TELEFLEX) 129ASTRA TECH, INC.-UROLOGY DIVISION 129TABLE 45 ASTRA TECH CATHETER PRODUCTS 130B BRAUN MELSUNGEN AG 130TABLE 46 B BRAUN CATHETER PRODUCTS 131BECTON DICKINSON & CO. 131TABLE 47 BD CATHETER PRODUCTS 132BOSTON SCIENTIFIC 132TABLE 48 BOSTON SCIENTIFIC CATHETER PRODUCTS 133TABLE 48 (CONTINUED) 134CARDINAL HEALTH 134TABLE 49 CARDINAL HEALTH CATHETER PRODUCTS 135COLOPLAST GROUP 135TABLE 50 COLOPLAST CATHETER PRODUCTS 136COOK MEDICAL 136TABLE 51 COOK MEDICAL CATHETER PRODUCTS 137TABLE 51 (CONTINUED) 138COVIDIEN (FORMERLY TYCO HEALTHCARE) 138TABLE 52 COVIDIEN CATHETER PRODUCTS 138TABLE 52 (CONTINUED) 139CR BARD 139TABLE 53 CR BARD CATHETER PRODUCTS 140TABLE 53 (CONTINUED) 141EDWARDS LIFESCIENCES 141TABLE 54 EDWARDS LIFESCIENCES CATHETER PRODUCTS 142EV3 ENDOVASCULAR, INC. 143TABLE 55 EV3 CATHETER PRODUCTS 143HOLLISTER 144TABLE 56 HOLLISTER CATHETER PRODUCTS 144HOSPIRA, INC. 144TABLE 57 HOSPIRA CATHETER PRODUCTS 145IRVINE BIOMEDICAL, INC. (SEE ST. JUDE MEDICAL) 145JOHNSON & JOHNSON 145TABLE 58 JOHNSON & JOHNSON CATHETER PRODUCTS 146
  • TABLE 58 (CONTINUED) 147MEDTRONIC, INC. 147TABLE 59 MEDTRONIC CATHETER PRODUCTS 148MERIT MEDICAL SYSTEMS 148TABLE 60 MERIT MEDICAL CATHETER PRODUCTS 149ROCHESTER MEDICAL 149TABLE 61 ROCHESTER MEDICAL CATHETER PRODUCTS 150SMITHS MEDICAL 150TABLE 62 SMITHS MEDICAL CATHETER PRODUCTS 151TABLE 62 (CONTINUED) 152ST. JUDE MEDICAL 152TABLE 63 ST. JUDE MEDICAL CATHETER PRODUCTS 153TELEFLEX MEDICAL (FORMERLY ARROW INTERNATIONAL) 153TABLE 64 ARROW/TELEFLEX MEDICAL CATHETER PRODUCTS 154TABLE 64 (CONTINUED) 155TERUMO MEDICAL CORP. 155TABLE 65 TERUMO CORP. CATHETER PRODUCTS 156TABLE 65 (CONTINUED) 157TYCO HEALTHCARE (SEE COVIDIEN) 157VASCULAR SOLUTIONS 157TABLE 66 VASCULAR SOLUTIONS CATHETER PRODUCTS 157APPENDIX: CATHETER PRODUCTS AND THEIR MANUFACTURERS 158TABLE 67 CATHETER PRODUCTS AND MANUFACTURERS 158TABLE 67 (CONTINUED) 159TABLE 67 (CONTINUED) 160TABLE 67 (CONTINUED) 161TABLE 67 (CONTINUED) 162TABLE 67 (CONTINUED) 163TABLE 67 (CONTINUED) 164TABLE 67 (CONTINUED) 165Latest Market Research Reports: LIver Disease Treatments: The Global Market Merchant Hydrogen Generation and On-site Distributed Generation Global Markets for Flame Retardant Chemicals and Plastics DNA Sequencing: Emerging Technologies and Applications 2011 Fuel Cell Industry Review 2011 Hybrid & Electric Vehicle Progree ReviewAbout Us:ReportsnReports is an online library of over 75,000 market research reports and in-depthmarket research studies & analysis of over 5000 micro markets. We provide 24/7 online andoffline support to our customers. Get in touch with us for your needs of market researchreports.Follow us on Twitter: http://twitter.com/marketsreportsOur Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689
  • Contact:Mr. Priyank7557 Rambler road,Suite 727, Dallas, TX 75231Tel: + 1 888 391 5441E-mail: sales@reportsandreports.comhttp://www.reportsnreports.comVisit Our Blog: Market Research Reports